Epstein sought to use his own genetic material for regenerative medicine, following his conviction for soliciting ...

Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations.

In this interview, Technology Networks spoke to Dr. Funda Meric-Bernstam about the landscape of personalized cancer therapy.

Jane Sykes, BVSc, DACVIM (SAIM), PhD, MPH, MBA, FNAP, discusses what researchers still don’t know about canine leptospirosis ...

When UNSW Associate Professor Shafagh Waters explains cystic fibrosis (CF) to the children she works with, she asks them to imagine what is happening inside their own bodies. "I tell them to picture ...

Sustained interest in small molecules, bispecific antibodies, and genomics got the ball rolling in the biotech deals arena in ...

New documents released by the DOJ reveal that Jeffrey Epstein paid for genetic testing in an effort to explore extending his ...

Convicted sex offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his own genetic material for regenerative medicine – which is aimed at repairing the body by developing ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year to $1.16 billion. The company’s full-year revenue guidance of $4.55 billion ...

Learn about a new conservation initiative that will preserve frozen samples collected from more than 10,000 species.

Precise MRD™ to transition from research-use-only into a limited clinical launch in March 2026SALT LAKE CITY, Jan. 27, 2026 ...

The emails were exchanged between Jeffrey Epstein and researcher Joseph Thakuria, who was working as a senior doctor at ...